Aug 11, 2020
1:30
For every 30 shares held, investors received 1.
The split itself did not change the total investment value.
Actinium Pharmaceuticals, Inc. (Delaware) (GETTEX:7AY1) operates in the Pharmaceuticals: major industry.
Actinium Pharmaceuticals, Inc. (Delaware) company overviewActinium Pharmaceuticals, Inc. (Delaware)'s most recent stock split was on August 11, 2020. It was a 1-for-30 reverse split, so shareholders received 1 share for every 30 they held.
Actinium Pharmaceuticals, Inc. (Delaware) (GETTEX:7AY1) has split its stock 2 times: a 1-for-2 reverse split on December 19, 2007 and a 1-for-30 reverse split on August 11, 2020.
Actinium Pharmaceuticals, Inc. (Delaware) has split its stock 2 times. This history records 2 reverse splits between December 19, 2007 and August 11, 2020.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Actinium Pharmaceuticals, Inc. (Delaware)'s 1-for-30 reverse split on August 11, 2020, every 30 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Actinium Pharmaceuticals, Inc. (Delaware) has not announced a new split in our records. Its most recent split was on August 11, 2020, 6 years ago. Companies announce splits in advance, and any new GETTEX:7AY1 split will appear on this page.